Precio de cierre
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
- PTS | -.--% | -.--% | -.--% |
14/05 | Transcript : Nykode Therapeutics AS, Q1 2024 Earnings Call, May 14, 2024 | |
14/05 | Nykode Therapeutics AS informa de los resultados del primer trimestre finalizado el 31 de marzo de 2024 | CI |
Resumen de negocios
Ventas por actividad
NOK en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Novel Vaccines and Immunotherapies
100,0
%
| 69 | 100,0 % | 136 | 100,0 % | +97,76 % |
Ventas por región
NOK en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 69 | 100,0 % | 136 | 100,0 % | +97,76 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Founder | 47 | 01/01/07 | |
Michael Engsig
CEO | Chief Executive Officer | - | 01/03/07 |
Harald Gurvin
DFI | Director of Finance/CFO | 49 | 03/05/21 |
Chief Tech/Sci/R&D Officer | 50 | 01/06/21 | |
Chief Tech/Sci/R&D Officer | - | 01/08/17 | |
Siri Torhaug
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/20 |
Mette Husbyn
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/17 |
Mona Welschof
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/13 |
Louise Stubbe
LAW | General Counsel | - | 01/01/22 |
Peter Fatum
PRN | Corporate Officer/Principal | - | 01/01/21 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Bernd Seizinger
BRD | Director/Board Member | 67 | - |
Director/Board Member | 64 | - | |
Director/Board Member | - | - | |
Chairman | 69 | 22/12/21 | |
Director/Board Member | 56 | - | |
Birgitte Volck
BRD | Director/Board Member | 61 | 05/05/21 |
Director/Board Member | 52 | - | |
Anders Tuv
BRD | Director/Board Member | 46 | - |
Elaine Sullivan
BRD | Director/Board Member | 63 | 13/05/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 326 546 444 | 179 598 448 ( 55,00 %) | 0 | 55,00 % |
Información de la empresa
Nykode Therapeutics ASA
Oslo Science Park Gaustadalléen 21
0349, Oslo
+47 22 95 81 93
http://www.nykode.comSector
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+9,42 % | 115 mil M | |
+11,84 % | 106 mil M | |
-1,05 % | 21,96 mil M | |
-14,15 % | 21,84 mil M | |
-5,29 % | 19,21 mil M | |
-4,16 % | 18,08 mil M | |
-38,29 % | 17,71 mil M | |
+7,99 % | 14,32 mil M | |
+36,24 % | 12,42 mil M |
- Bolsa de valores
- Acciones
- Acción VACC
- Acción VACC
- Empresa VACY AS